BCAT2 Polyclonal Antibody

BCAT2 Polyclonal Antibody

The BCAT2 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and quantification of BCAT2 protein in various biological samples. This antibody has been extensively validated for its exceptional performance in immunohistochemistry (IHC), immunofluorescence (IF), and western blotting (WB) applications.

The BCAT2 protein, also known as branched-chain amino acid transaminase 2, plays a crucial role in the metabolism of branched-chain amino acids (BCAAs). It catalyzes the reversible transamination of BCAAs, thereby contributing to the regulation of their levels in the body. Dysregulation of BCAT2 has been implicated in various diseases, including cancer, metabolic disorders, and neurological disorders.

The BCAT2 Polyclonal Antibody has been meticulously developed using high-quality materials and advanced techniques to ensure superior specificity and sensitivity. It exhibits minimal cross-reactivity with other proteins, enabling accurate and precise detection of BCAT2 in complex biological samples.

This antibody demonstrates exceptional performance in IHC, allowing for the visualization and localization of BCAT2 protein in tissue sections. It also exhibits robust fluorescence signals in IF, enabling the examination of BCAT2 expression patterns in cells and tissues. Additionally, the BCAT2 Polyclonal Antibody exhibits strong and specific bands in WB, facilitating the quantification of BCAT2 protein levels.

The BCAT2 Polyclonal Antibody is supplied as a liquid formulation in a convenient size, ensuring ease of use and storage. It is compatible with various experimental conditions and can be used in a wide range of species, including human, mouse, and rat.

In summary, the BCAT2 Polyclonal Antibody is a highly reliable and specific tool for the detection and quantification of BCAT2 protein. Its exceptional performance in IHC, IF, and WB applications, along with its compatibility with multiple species, makes it an invaluable asset for researchers studying BCAT2 and its implications in various diseases.